Aristolochic acid nephropathy, a global health problem

Aristolochic acid nephropathy, a global health problem
Although the first description of a rapidly progressive nephropathy associated with the consumption of aristolochic acid found in Chinese herbs was first reported 20 years ago, aristolochic acid-induced nephropathy remains a worldwide health concern due to the lack of regulation on herbal medication and the easy availability of such medications online, according to a review published in the March 19 issue of the Annals of Internal Medicine.

(HealthDay)—Although the first description of a rapidly progressive nephropathy associated with the consumption of aristolochic acid (AA) found in Chinese herbs was first reported 20 years ago, AA-induced nephropathy remains a worldwide health concern due to the lack of regulation on herbal medication and the easy availability of such medications online, according to a review published in the March 19 issue of the Annals of Internal Medicine.

M. Refik Gokmen, Ph.D., M.B.B.S., of King's College London and Imperial College London, and colleagues used an evidence-based approach to review the epidemiology, diagnosis, and management of AA-induced .

According to the authors, herbal medicinal products containing AA have been, and continue to be, used worldwide for various indications such as eczema, acne, liver symptoms, arthritis, and chronic pain. The exact mechanisms of AA-induced nephrotoxicity are not fully characterized. Most patients diagnosed with AA-induced nephropathy showed an unusually rapid progression toward end-stage renal disease. Cumulative AA dose is likely associated with the degree of renal insufficiency and the rate of decline in renal function. No serum or urinary biomarkers have been shown to aid in the diagnosis of AA-induced nephropathy. can only be made with histological examination. There are no known therapeutic agents that can reverse or delay progression of AA-induced nephropathy.

"We have attempted in this review to fill in the many evidence gaps about all aspects of this disease on the basis of our clinical experience and consensus, but future research should seek to determine noninvasive biomarkers of exposure and disease and optimum agents and surgical treatments that might alter the course of the disease," the authors write. "Perhaps most important, improved regulation of could help eradicate this entirely preventable illness."

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Rapidly progressive alopecia shows favorable prognosis

Oct 09, 2012

(HealthDay)—Patients with rapidly progressive alopecia areata (RPAA) tend to show favorable prognosis regardless of treatment selected, according to research published online Sept. 24 in the Journal of ...

Recommended for you

Researchers gain new insights into hypothyroidism

5 minutes ago

An international research team led by physician-scientists at Rush University Medical Center has gained new insights into hypothyroidism - a condition affecting about 10 million people in the U.S. - that may lead to new treatment ...

Liberia closes Ebola centre at epicentre of outbreak

3 hours ago

Liberia's president on Monday announced the closure of an Ebola treatment facility which lay at the epicentre of the virus's worst outbreak in history, as the disease's spread has slowed in the country.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.